Breast Health
All Breast Health articles
566 articles · showing 541–566
FDA approves Aromasin for use in post-menopausal breast cancer patients (dateline November 22, 1999)
The U.S. Food and Drug Administration recently approved the drug Aromasin (generic name, exemestane) to treat advanced stage breast cancer in post-menopausal patients.
Climb Against The Odds: Breast Cancer Survivors Climb Mount McKinley (dateline November 22, 1999)
Photo courtesy of the Breast Cancer Research Fund (http://www.breastcancerfund.org)An award-winning documentary, "Climb Against the Odds: A Story of Courage and Survival as Twelve Women Fight Breast Cancer at 20,000 Feet," recently premiered on the Public Broadcasting System (PBS), documenting the 1
Bosom Buddies: Lessons and Laughter on Breast Health and Cancer by RosieO’Donnell and Deborah Axelrod (dateline November 17, 1999)
Popular talk-show host Rosie O’Donnell has teamed up with her own breast health specialist, Dr. Deborah Axelrod, to bring women a new book about breast cancer: Bosom Buddies: Lessons and Laughter on Breast Health and Cancer .
Experimental Microwave Treatment May Reduce Breast Cancer Surgeries (dateline November 12, 1999)
Researchers at the Columbia Hospital Center for Breast Care in West Palm Beach, Florida will conduct a new breast cancer clinical study that uses heat energy from microwaves to kill breast tumors.
Link Between BRCA1 Gene And ATM Protein May Explain Increased Breast Cancer Risk (dateline November 11, 1999)
Scientists at the Baylor College of Medicine in Houston, Texas have discovered that the protein kinase ATM (ataxia telangiectasia) works with the BRCA1 tumor suppressor protein to repair cellular DNA damage.
FDA approves Taxol for early breast cancer treatment (dateline November 10, 1999)
The U.S. Food and Drug Administration recently approved the anti-cancer drug Taxol (generic name paclitaxel) to treat early stage breast cancer that has spread to the lymph nodes under the arm.
Non-toxic Drug Fenretinide May Reduce Recurrent Breast Cancer (dateline November 5, 1999)
A preliminary study reveals that fenretinide, a non-toxic drug related to Vitamin A, may significantly reduce recurrent breast cancer in pre-menopausal women.
Researchers Skeptical About Link Between Breast Cancer And Dry Cleaning, Lawn Service (dateline October 28, 1999)
A number of small studies over the past few years have shown a possible increased incidence of breast cancer in women who use dry cleaning services or professional lawn services.
Rescued From The South Pole, Dr. Nielsen Confirms She Has Breast Cancer (dateline October 26, 1999)
Dr. Jerri Nielsen, 47, returned to the United States last week after the U.S. National Guard air-lifted her from the National Science Foundation’s Amundsen-Scott research station at the South Pole on October 16, 1999. Dr.
Researchers Will Begin Testing Endostatin On Cancer Patients (dateline October 26, 1999)
After much anticipation, researchers will begin testing the effects of the tumor-starving drug endostatin in humans this week.
Genetic Testing May Lead To Less Invasive Treatment Of Early Breast Cancer (dateline October 22, 1999)
A recent study by Dr. Ayman Linjawi of the Royal Victoria Hospital in Montreal, Quebec, Canada reveals that the expression of the mutant bcl-2 gene and p53 tumor suppressor in women with early stage breast cancer may lead to treatment with tamoxifen and chemotherapy, preventing more invasive surgica
Fibrin Sealant Reduces Fluid Accumulation After Breast Surgery (dateline October 21, 1999)
A study at the University of Virginia Health Sciences Center reveals that using fibrin sealant significantly reduces total fluid drainage in patients undergoing modified radical mastectomy with axillary node dissection .
Update: Doctor With Breast Cancer Rescued From South Pole (dateline October 18, 1999)
After two days of waiting for temperatures to rise to minus fifty-eight degrees Celsius (seventy-two degrees below zero Fahrenheit), a United States National Guard cargo plane rescued Dr. Jerri Nielsen from the South Pole. Through satellite consultation with U.S. doctors, Dr.
False Rumor Says Antiperspirants Cause Breast Cancer (dateline October 14, 1999)
Over the past few months, an inaccurate e-mail message has been broadly circulated stating that the use of antiperspirants is a leading cause of breast cancer.
High-dose Chemotherapy Improves Breast Cancer Survival (dateline October 13, 1999)
A recent study led by Dr. David A. Rizzieri of Duke University Medical Center revealed that the early use of high-dose chemotherapy and other aggressive treatment of metastatic breast cancer may significantly improve a patient’s outcome, compared to standard-dose chemotherapy.
Update: Attempt To Rescue Doctor With Breast Cancer At South Pole Is Delayed (dateline October 13, 1999)
LC130 just after landing at the South Pole last summer. After a twenty-four hour weather delay in New Zealand, the two Air National Guard LC-130 cargo planes attempting to rescue Dr.
Clinical Breast Exams Can Be Improved With More Standardization (dateline October 12, 1999)
A new study reveals that clinical breast examinations performed by health care professional are not consistent. A more standardized technique could lead to earlier breast cancer diagnoses, and in turn, could reduce the breast cancer mortality rate.
FDA approves Sensibility breast self-examination pad (dateline October 11, 1999)
For the first time, the Food and Drug Administration has approved a non-prescription breast self-examination (BSE) pad for at-home use. The Sensibility breast pad is distributed by B-D, Inc.
Drug Industry Prepares for Y2K Rush on Prescription Medicines (dateline October 11, 1999)
With the end of the millennium less than three months away, the health care industry predicts customers will rush to stock up on prescription medicines.
Doctor With Breast Cancer Will Be Air-Lifted From South Pole (dateline October 6, 1999)
Two LC-130 Air National Guard cargo planes equipped with ski landing gear left Scotia, New York on Wednesday to rescue Dr. Jerri Nielsen, a medical doctor on the United States Amundsen-Scott South Pole Research Station in Antarctica who has breast cancer.
FDA Approves ELLENCE, A New Breast Cancer Treatment (dateline September 16, 1999)
Data shows ELLENCE reduces risk of death and cancer recurrence in women with early breast cancer; could save thousands of lives each year. Pharmacia & Upjohn today announced that the U.S.
New Research Sheds Light On Why Women Build Resistance To Tamoxifen Breast Cancer Therapy (dateline July 30, 1999)
Breast cancer patients taking the drug tamoxifen (trade name Novaldex) generally develop resistance to the drug two to five years into treatment.
New guidelines help doctors determine which women should be offered tamoxifen to prevent breast cancer (dateline May 18, 1999)
How do women determine if they are at risk for breast cancer? ASCO recommendations are disputed by some Role of raloxifene in preventing breast cancer Summary conclusion from the ASCO Report Additional information and references Study of tamoxifen and raloxifene (STAR) trial A new study suggests tha
New FDA Mammography Act Requires Facilities to Provide Written Results to Patients within 30 days (dateline May 3, 1999)
As of April 28, 1999, all women who have mammograms must be informed of the results in writing, under the U.S. Food and Drug Administration (FDA) Mammography Quality Standards Reauthorization Act of 1998.
New FDA Mammography Act Requires Facilities to Provide Written Results to Patients within 30 days (dateline April 28, 1999)
As of April 28, 1999, all women who have mammograms must be informed of the results in writing, under the U.S. Food and Drug Administration (FDA) Mammography Quality Standards Reauthorization Act of 1998.
Duke University Study Renews Hope For Use of Angiostatin to Shrink Cancer Tumors (dateline March 16, 1999)
Angiostatin and endostatin have been among the most exciting items in cancer research over the past year. These drugs shrink cancer tumors to the size of a pinhead by choking off the blood supply to the tumors. But despite optimistic media attention there have been some major obstacles.